Avalo Therapeutics Investor Relations Material
Latest events
Q2 2025
7 Aug, 2025
Corporate Presentation
19 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avalo Therapeutics Inc
Access all reports
Avalo Therapeutics Inc. is a U.S.-based biotechnology company focused on the development of targeted therapies for immune-mediated diseases. The company specializes in discovering and advancing treatments for autoimmune and rare diseases by leveraging its expertise in immunology and precision medicine. Avalo Therapeutics Inc. conducts research across various stages of drug development, from early discovery to clinical trials. The company is headquartered in Rockville, Maryland, and its shares are listed on the NASDAQ.
Key slides for Avalo Therapeutics Inc
Corporate Presentation
Avalo Therapeutics Inc
Corporate Presentation
Avalo Therapeutics Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
AVTX
Country
🇺🇸 United States